Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

A recent RAND survey reveals that 12% of Americans have tried GLP-1 drugs like Ozempic for weight loss, with usage highest ...

Serena Williams is noticeably slimmer now than she was when she retired from the WTA Tour in 2022. Last month she revealed how that happened.

Initially marketed as diabetes treatments, GLP-1 drugs are now surging in popularity as weight loss solutions. With more ...

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live ...

GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...

Analysis led by Mass General Brigham researchers shows tirzepatide offers greater value than semaglutide for most patients• For eligible and willing ...

Increased spending for the medications like Wegovy and Ozempic in Delaware is not being driven by inflated drug prices, but ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk ...

Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers ...

The World Health Organization (WHO) now supports the use of GLP-1 drugs like semaglutide (Ozempic, Wegovy) for long-term obesity treatment in adults w ...